{
  "id": 8897108,
  "title": "World Alzheimer's Day: How the UAE is making a difference",
  "url": "https://urgent.news/2026/09/21/world-alzheimers-day-how-the-uae-is-making-a-difference",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-21T10:00:00.000Z",
  "source": {
    "name": "The National Business",
    "slug": "the-national-business",
    "url": "https://www.thenationalnews.com/opinion/editorial/2026/09/21/alzheimers-disease-aging-health-science-research-middle-east/"
  },
  "original_language": "en",
  "account": "World Alzheimer's Day brings a ray of hope as the UAE steps up its efforts to combat this debilitating cognitive illness. According to a recent report from Alzheimer’s Disease International, nearly 160 potential therapies are currently in trials globally, with experts predicting a revolution in the field reminiscent of cancer care advancements. However, the Middle East, home to one of the world's fastest-aging populations, faces a challenge due to a relative lack of international trials, which often focus on predominantly white populations.\n\nThe UAE has a unique advantage in addressing this imbalance, thanks to its Emirati Genome Programme. This initiative has enlisted nearly a million UAE citizens to share their genetic data, aiding research and studies. In July, Abu Dhabi utilized this information to identify high-risk individuals for an Alzheimer's trial of a preventive therapy.\n\nMoreover, the UAE's genome project highlights the population's willingness to participate in scientific experiments and data collection when well explained. This participatory goodwill is crucial for bridging research gaps. Active dementia trials require approximately 55,000 global participants, necessitating a pool of around 350,000 volunteers due to many unsuitable candidates.\n\nThe UAE's diverse population, comprising over 200 nationalities, makes it an ideal location for conducting trials. This diversity offers both social and scientific benefits. Currently, dementia trials struggle with low awareness, limited doctor referrals, and strict eligibility criteria. To overcome these challenges, hospitals, clinicians, and governments should simplify trial participation, providing clear referral routes and straightforward explanations.\n\nBy promoting trial participation as a civic contribution, the UAE can lead the region in designing medical trials suited for its population. This, in turn, can foster scientific discoveries of international significance, bringing hope not only to those directly affected but also to the broader scientific community.",
  "summary": "Dementia care has waited a long time for a piece of good news, and some good news has finally arrived. According to a new report from Alzheimer’s Disease International, nearly 160 potential therapies are now in trials worldwide, and experts say the field is on the cusp of a revolution, much like the one that is transforming cancer care. After decades of frustration, such treatments could loosen…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The National UAE",
        "title": "World Alzheimer's Day: How the UAE is making a difference",
        "url": "https://urgent.news/2026/09/21/world-alzheimers-day-how-the-uae-is-making-a-difference-8898324",
        "published": "2026-09-21T10:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}